Donald Notman | Chief Financial Officer |
Antony Mattessich | President and Chief Executive Officer |
Michael Goldstein | President-Ophthalmology and Chief Medical Officer |
Joe Catanzaro | Piper Sandler |
Jonathan Wollenben | JMP Securities |
Georgi Yordanov | Cowen and Company |
Ed Chung | Jefferies |
Anita Dushyanth | Berenberg |
Boobalan Pachaiyappan | H.C. Wainwright |
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Ocular Therapeutix First Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. It is now my pleasure to turn the call over to Donald Notman, Chief Financial Officer of Ocular Therapeutix.